No Data
No Data
ENZOLYTICS, INC. SHAREHOLDERS HOLD SPECIAL MEETING AND ELECT NEW BOARD
Board Appoints Officers ALLEN, Texas, March 25, 2024 /PRNewswire/ -- Enzolytics, Inc. (OTC PINK:ENZC) (" Enzolytics, Inc. (the "Company") On March 19th, 2024, a Special Meeting of the Shareholders o
Enzolytics Announces The Signing Of The Business Combination Agreement With Sagaliam Acquisition Corp
Enzolytics, Inc. (OTC:ENZC) (Enzolytics, Inc. announces today that it has executed the binding business combination agreement for the sale of Biogenysis, Inc. ("BGEN") and Virogentics Inc. ("VIRO"), t
Biogenysis Inc. Announces a Collaboration With Khalpey AI Lab in Using Artificial Intelligence...
Enzolytics Inc. Files Supplemental Information Report on the Sale of Biogenysis, Inc. and Virogentics, Inc to Sagaliam Acquisition Corp.
COLLEGE STATION, TX / ACCESSWIRE / July 11, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (Enzolytics, Inc. ("ENZC" or the "Company") filed a Supplemental Information report today to provide additional deta
SPAC Sagaliam, Enzolytics Agree to Raise Price of Unit Sale to $450M
Sagaliam Acquisition Corp. Announces Amendment to Non-Binding Term Sheet With Enzolytics Inc. and Addition of New Board Members
NEW YORK, NY / ACCESSWIRE / June 30, 2023 / Sagaliam Acquisition Corp. (NASDAQ:"SAGAU", "SAGA", "SAGAR") ("we", "us", "our", or the "Company") announced today that it has amended the executed non-bind
No Data